Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135525 (US8853258, 176) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0303 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135565 (US8853258, 218) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0340 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135527 (US8853258, 178) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0592 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135477 (US8853258, 44) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0669 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135531 (US8853258, 182) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0674 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135562 (US8853258, 215) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.0842 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135460 (US8853258, 5) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.120 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135494 (US8853258, 104) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.127 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135478 (US8853258, 47) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.132 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135495 (US8853258, 107) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.134 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135530 (US8853258, 181) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.138 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135497 (US8853258, 109) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.144 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135498 (US8853258, 113) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.148 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135502 (US8853258, 127) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.150 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135533 (US8853258, 184) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.155 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135528 (US8853258, 179) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 0.172 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135496 (US8853258, 108) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.176 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135472 (US8853258, 23) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.180 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135484 (US8853258, 62) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.185 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM30550 (US8853258, 194) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.195 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135518 (US8853258, 169) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135506 (US8853258, 136) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.205 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135483 (US8853258, 59) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.213 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135503 (US8853258, 128) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.232 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135516 (US8853258, 167) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.235 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135560 (US8853258, 212) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.237 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135535 (US8853258, 186) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.238 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135549 (US8853258, 201) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.240 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135513 (US8853258, 162) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.241 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135490 (US8853258, 83) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.242 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135539 (US8853258, 190) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.246 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135459 (US8853258, 2) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.260 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135547 (US8853258, 199) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.266 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135492 (US8853258, 91) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.266 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135564 (US8853258, 217) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.278 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135465 (US8853258, 13) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.290 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135482 (US8853258, 57) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.295 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135514 (US8853258, 165) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.295 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135526 (US8853258, 177) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.306 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135462 (US8853258, 7) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.310 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135463 (US8853258, 9) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135573 (US8853258, 226) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.320 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM30560 (US8853258, 247) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.325 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135501 (US8853258, 126) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.329 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135474 (US8853258, 34) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.331 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135476 (US8853258, 42) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.335 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135507 (US8853258, 138) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.335 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135508 (US8853258, 157) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.337 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135537 (US8853258, 188) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.348 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
UDP-3-O-acyl-N-acetylglucosamine deacetylase (Pseudomonas aeruginosa) | BDBM135485 (US8853258, 63) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.356 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Pfizer Inc. US Patent | Assay Description IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx... | US Patent US8853258 (2014) BindingDB Entry DOI: 10.7270/Q25M64DP | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 197 total ) | Next | Last >> |